Clinical Trials Browser

Phase 2 × Terminated × HER2-positive Breast Cancer × Clear all

NCT07166367 2025-09-10

Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer

Phase 2 Terminated

HER2-positive Breast Cancer